The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial

Name: The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial
Published: 2017
License: Public Domain

University Health Network, Toronto · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

immune-checkpoint melanoma pembrolizumab

advanced ovarian cancer, malignant melanoma, adoptive cell therapy, melanoma, ovarian, cyclophosphamide, fludarabine, tumor-infiltrating lymphocytes (tils), pembrolizumab, interleukin-2, anti-pd-1, immune checkpoint

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 811414
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.